Sanara MedTech Inc. (SMTI) stock
Close on Nov 18, 2026Market cap $300.72MP/E –Yield –
Earnings
Sanara MedTech's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Sanara MedTech's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 23, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 12, 2026after the close | $28.40M | +8.0% | -$0.15 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 11, 2026after the close | – | – | – | Release |
| Q1 FY2026ended Mar 31, 2026 | May 11, 2026after the close | $27.80M | – | $0.05 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 24, 2026before the open | $27.50M | +4.6% | -$0.19 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 12, 2025before the open | $26.30M | +21.2% | -$3.40 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 13, 2025before the open | $25.80M | +27.7% | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 14, 2025before the open | – | – | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 25, 2025before the open | $26.30M | +48.6% | -$0.18 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 12, 2024after the close | $21.70M | +35.6% | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 12, 2024after the close | $20.20M | +27.8% | -$0.41 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 13, 2024before the open | $18.50M | +19.4% | -$0.21 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 25, 2024after the close | $17.70M | – | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 13, 2023after the close | $16.00M | +23.1% | -$0.13 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 14, 2023after the close | $15.80M | +62.9% | -$0.22 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 15, 2023after the close | $15.50M | +98.7% | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 20, 2023after the close | – | – | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 14, 2022after the close | $13.00M | +123.2% | – | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 15, 2022after the close | $9.70M | – | – | Release |
| Q1 FY2022ended Mar 31, 2022 | May 16, 2022after the close | $7.80M | – | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 30, 2022after the close | – | – | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 15, 2021before the open | $5.82M | – | – | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 16, 2021after the close | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Jan 25, 2021after the close | – | – | – | Filing |
| Q2 FY2020ended Jun 30, 2020 | Jul 8, 2020during market hours | – | – | – | Filing |
| Q1 FY2020ended Mar 31, 2020 | Apr 17, 2020during market hours | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Sanara MedTech's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| growth | FY2026 | +13% – +17% | – | New | May 11, 2026 |
| net revenue | FY2026 | $110.00M – $115.00M | $116.00M – $121.00M | Lowered | Nov 12, 2026 |
| net revenue | FY2026 | $116.00M – $121.00M | – | New | May 11, 2026 |
| net revenueGAAP | FY2026 | $116.00M – $121.00M | – | New | Jan 23, 2026 |
Guidance history
Every forecast Sanara MedTech put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 12, 2026 | net revenue | FY2026 | $110.00M – $115.00M | Lowered |
| May 11, 2026 | R&D | annual basis | 5% – 7% | – |
| May 11, 2026 | growth | Q2 FY2026 | +10% – +14% | New |
| May 11, 2026 | net revenue | FY2026 | $116.00M – $121.00M | New |
| May 11, 2026 | growth | FY2026 | +13% – +17% | New |
| May 11, 2026 | net revenue | Q2 FY2026 | $28.50M – $29.50M | New |
| Mar 24, 2026 | net revenue | FY2026 | $116.00M – $121.00M | New |
| Jan 23, 2026 | net revenue | FY2026 | $116.00M – $121.00M | New |
| Nov 12, 2025 | total cash investment in THP | FY2025 | $5.50M – $6.50M | Reaffirmed |
| Aug 13, 2025 | cash investment during the second half of 2025 | FY2025 | $5.50M – $6.50M | Lowered |
| Mar 25, 2025 | continued investment in Tissue Health Plus | FY2025 | $7.50M – $10.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Sanara MedTech filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Results
- Results
- Update
- Results
- Update
- Results
- Results
- Update
- Results
- Update
- Results
- Update
See a number that looks wrong?